{"pmid":32336578,"title":"Could telehealth help eye care practitioners adapt contact lens services during the COVID-19 pandemic?","text":["Could telehealth help eye care practitioners adapt contact lens services during the COVID-19 pandemic?","The COVID-19 pandemic has necessitated government-imposed restrictions on social interactions and travel. For many, the guidance has led to new ways of working, most notably a shift towards working remotely. While eye care practitioners (ECPs) may continue to provide urgent or emergency eye care, in many cases the travel restrictions present a unique challenge by preventing conventional face-to-face examination. Telephone triage provides a useful starting point for establishing at-risk and emergency patients; but patient examination is central to contact lens patient care. The indeterminate period over which conventional practice will be suspended, and the risk that resumption of 'normal' practice could be impeded by a potential secondary peak in COVID-19 cases, hastens the need for practitioners to adapt their delivery of eyecare. Specifically, it is prudent to reflect upon supportive evidence for more comprehensive approaches to teleoptometry in contact lens practice. Smartphone based ocular imaging is an area which has seen considerable growth, particularly for imaging the posterior eye. Smartphone imaging of the anterior eye requires additional specialised instrumentation unlikely to be available to patients at home. Further, there is only limited evidence for self-administered image capture. In general, digital photographs, are useful for detection of gross anterior eye changes, but subtle changes are less discernible. For the assessment of visual acuity, many electronic test charts have been validated for use by practitioners. Research into self-administered visual acuity measures remains limited. The absence of a comprehensive evidence base for teleoptometry limits ECPs, particularly during this pandemic. Knowledge gaps ought to be addressed to facilitate development of optometry specific evidence-based guidance for telecare. In particular, advances in ocular self-imaging could help move this field forwards.","Cont Lens Anterior Eye","Nagra, Manbir","Vianya-Estopa, Marta","Wolffsohn, James S","32336578"],"abstract":["The COVID-19 pandemic has necessitated government-imposed restrictions on social interactions and travel. For many, the guidance has led to new ways of working, most notably a shift towards working remotely. While eye care practitioners (ECPs) may continue to provide urgent or emergency eye care, in many cases the travel restrictions present a unique challenge by preventing conventional face-to-face examination. Telephone triage provides a useful starting point for establishing at-risk and emergency patients; but patient examination is central to contact lens patient care. The indeterminate period over which conventional practice will be suspended, and the risk that resumption of 'normal' practice could be impeded by a potential secondary peak in COVID-19 cases, hastens the need for practitioners to adapt their delivery of eyecare. Specifically, it is prudent to reflect upon supportive evidence for more comprehensive approaches to teleoptometry in contact lens practice. Smartphone based ocular imaging is an area which has seen considerable growth, particularly for imaging the posterior eye. Smartphone imaging of the anterior eye requires additional specialised instrumentation unlikely to be available to patients at home. Further, there is only limited evidence for self-administered image capture. In general, digital photographs, are useful for detection of gross anterior eye changes, but subtle changes are less discernible. For the assessment of visual acuity, many electronic test charts have been validated for use by practitioners. Research into self-administered visual acuity measures remains limited. The absence of a comprehensive evidence base for teleoptometry limits ECPs, particularly during this pandemic. Knowledge gaps ought to be addressed to facilitate development of optometry specific evidence-based guidance for telecare. In particular, advances in ocular self-imaging could help move this field forwards."],"journal":"Cont Lens Anterior Eye","authors":["Nagra, Manbir","Vianya-Estopa, Marta","Wolffsohn, James S"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32336578","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.clae.2020.04.002","keywords":["anterior eye segment","covid-19","contact lenses","evidence based healthcare","telehealth","teleoptometry"],"topics":["Prevention"],"weight":1,"_version_":1665264685663911937,"score":8.574329,"similar":[{"pmid":32273245,"pmcid":"PMC7129028","title":"The COVID-19 pandemic: Important considerations for contact lens practitioners.","text":["The COVID-19 pandemic: Important considerations for contact lens practitioners.","A novel coronavirus (CoV), the Severe Acute Respiratory Syndrome Coronavirus - 2 (SARS-CoV-2), results in the coronavirus disease 2019 (COVID-19). As information concerning the COVID-19 disease continues to evolve, patients look to their eye care practitioners for accurate eye health guidance. There is currently no evidence to suggest an increased risk of contracting COVID-19 through contact lens (CL) wear compared to spectacle lens wear and no scientific evidence that wearing standard prescription spectacles provides protection against COVID-19 or other viral transmissions. During the pandemic there will potentially be significant changes in access to local eyecare. Thus, it is imperative CL wearers are reminded of the steps they should follow to minimise their risk of complications, to reduce their need to leave isolation and seek care. Management of adverse events should be retained within optometric systems if possible, to minimise the impact on the wider healthcare service, which will be stretched. Optimal CL care behaviours should be the same as those under normal circumstances, which include appropriate hand washing (thoroughly with soap and water) and drying (with paper towels) before both CL application and removal. Daily CL cleaning and correct case care for reusable CL should be followed according to appropriate guidelines, and CL exposure to water must be avoided. Where the availability of local clinical care is restricted, practitioners could consider advising patients to reduce or eliminate sleeping in their CL (where patients have the appropriate knowledge about correct daily care and access to suitable lens-care products) or consider the option of moving patients to daily disposable lenses (where patients have appropriate lens supplies available). Patients should also avoid touching their face, including their eyes, nose and mouth, with unwashed hands and avoid CL wear altogether if unwell (particularly with any cold or flu-like symptoms).","Cont Lens Anterior Eye","Jones, Lyndon","Walsh, Karen","Willcox, Mark","Morgan, Philip","Nichols, Jason","32273245"],"abstract":["A novel coronavirus (CoV), the Severe Acute Respiratory Syndrome Coronavirus - 2 (SARS-CoV-2), results in the coronavirus disease 2019 (COVID-19). As information concerning the COVID-19 disease continues to evolve, patients look to their eye care practitioners for accurate eye health guidance. There is currently no evidence to suggest an increased risk of contracting COVID-19 through contact lens (CL) wear compared to spectacle lens wear and no scientific evidence that wearing standard prescription spectacles provides protection against COVID-19 or other viral transmissions. During the pandemic there will potentially be significant changes in access to local eyecare. Thus, it is imperative CL wearers are reminded of the steps they should follow to minimise their risk of complications, to reduce their need to leave isolation and seek care. Management of adverse events should be retained within optometric systems if possible, to minimise the impact on the wider healthcare service, which will be stretched. Optimal CL care behaviours should be the same as those under normal circumstances, which include appropriate hand washing (thoroughly with soap and water) and drying (with paper towels) before both CL application and removal. Daily CL cleaning and correct case care for reusable CL should be followed according to appropriate guidelines, and CL exposure to water must be avoided. Where the availability of local clinical care is restricted, practitioners could consider advising patients to reduce or eliminate sleeping in their CL (where patients have the appropriate knowledge about correct daily care and access to suitable lens-care products) or consider the option of moving patients to daily disposable lenses (where patients have appropriate lens supplies available). Patients should also avoid touching their face, including their eyes, nose and mouth, with unwashed hands and avoid CL wear altogether if unwell (particularly with any cold or flu-like symptoms)."],"journal":"Cont Lens Anterior Eye","authors":["Jones, Lyndon","Walsh, Karen","Willcox, Mark","Morgan, Philip","Nichols, Jason"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32273245","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.clae.2020.03.012","keywords":["covid-19","contact lens","lens care","lens wear"],"source":"PubMed","topics":["Prevention"],"weight":1,"e_drugs":["Water"],"_version_":1664637190153437185,"score":565.34644},{"pmid":32337386,"pmcid":"PMC7179507","title":"Practice considerations for proton beam radiotherapy of uveal melanoma during the COVID-19 pandemic: PTCOG Ocular experience.","text":["Practice considerations for proton beam radiotherapy of uveal melanoma during the COVID-19 pandemic: PTCOG Ocular experience.","Uveal melanoma (UM) is a rare but life-threatening cancer of the eye. In light of the COVID-19 pandemic, hospitals and proton eye therapy facilities must analyze several factors to ensure appropriate treatment protocols for patients and provider teams. Practice considerations to limit COVID-19 transmission in the proton ocular treatment setting for UM are necessary. The Particle Therapy Co-Operative Group (PTCOG) is the largest international community of particle/proton therapy providers. Participating experts are/were affiliated with the member institutions of the PTCOG Ocular subcommittee with long-standing high-volume proton ocular programs. The practices reviewed in this document must be taken in conjunction with local hospital procedures, multidisciplinary recommendations, and regional/national guidelines, as each community may have its unique needs, supplies, and protocols. Importantly, as the pandemic evolves, so will the strategies and recommendations. Given the unique circumstances for UM patients, along with indications of potential ophthalmologic transmission as a result of healthcare providers working in close proximity to patients and intrinsic infectious risk from eyelashes, tears and hair, practice strategies may be adapted to reduce the risk of viral transmission. Certainly, providers and health care systems will continue to examine and provide as safe and effective care as possible for patients in the current environment.","Adv Radiat Oncol","Mishra, K K","Afshar, A","Thariat, J","Shih, H A","Scholey, J E","Daftari, I K","Kacperek, A","Pica, A","Hrbacek, J","Dendale, R","Mazal, A","Heufelder, J","Char, D H","Sauerwein, W","Weber, D C","Damato, B E","32337386"],"abstract":["Uveal melanoma (UM) is a rare but life-threatening cancer of the eye. In light of the COVID-19 pandemic, hospitals and proton eye therapy facilities must analyze several factors to ensure appropriate treatment protocols for patients and provider teams. Practice considerations to limit COVID-19 transmission in the proton ocular treatment setting for UM are necessary. The Particle Therapy Co-Operative Group (PTCOG) is the largest international community of particle/proton therapy providers. Participating experts are/were affiliated with the member institutions of the PTCOG Ocular subcommittee with long-standing high-volume proton ocular programs. The practices reviewed in this document must be taken in conjunction with local hospital procedures, multidisciplinary recommendations, and regional/national guidelines, as each community may have its unique needs, supplies, and protocols. Importantly, as the pandemic evolves, so will the strategies and recommendations. Given the unique circumstances for UM patients, along with indications of potential ophthalmologic transmission as a result of healthcare providers working in close proximity to patients and intrinsic infectious risk from eyelashes, tears and hair, practice strategies may be adapted to reduce the risk of viral transmission. Certainly, providers and health care systems will continue to examine and provide as safe and effective care as possible for patients in the current environment."],"journal":"Adv Radiat Oncol","authors":["Mishra, K K","Afshar, A","Thariat, J","Shih, H A","Scholey, J E","Daftari, I K","Kacperek, A","Pica, A","Hrbacek, J","Dendale, R","Mazal, A","Heufelder, J","Char, D H","Sauerwein, W","Weber, D C","Damato, B E"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32337386","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.adro.2020.04.010","topics":["Prevention"],"weight":1,"_version_":1665264685650280450,"score":310.31775},{"pmid":32306555,"title":"Forced Disruption of Anatomy Education in Australia and New Zealand: An Acute Response to the Covid-19 Pandemic.","text":["Forced Disruption of Anatomy Education in Australia and New Zealand: An Acute Response to the Covid-19 Pandemic.","Australian and New Zealand universities commenced a new academic year in February/March 2020 largely with 'business as usual'. The subsequent COVID-19 pandemic imposed unexpected disruptions to anatomical educational practice. Rapid change occurred due to government-imposed physical distancing regulations from March 2020 that increasingly restricted anatomy laboratory teaching practices. Anatomy educators in both these countries were mobilized to adjust their teaching approaches. This study on anatomy education disruption at pandemic onset within Australia and New Zealand adopts a social constructivist lens. The research question was \"What are the perceived disruptions and changes made to anatomy education in Australia and New Zealand during the initial period of the Covid-19 pandemic, as reflected on by anatomy educators?\". Thematic analysis to elucidate ''the what and why'' of anatomy education was applied to these reflections. Eighteen anatomy academics from ten institutions participated in this exercise. The analysis revealed loss of integrated 'hands-on' experiences, and impacts on workload, traditional roles, students, pedagogy and anatomists' personal educational philosophies. The key opportunities recognized for anatomy education included: enabling synchronous teaching across remote sites, expanding offerings into the remote learning space, and embracing new pedagogies. In managing anatomy education's transition in response to the pandemic, six critical elements were identified: community care, clear communications, clarified expectations, constructive alignment, community of practice, ability to compromise and adapt and continuity planning. There is no doubt that anatomy education has stepped into a yet unknown future in the island countries of Australia and New Zealand.","Anat Sci Educ","Pather, Nalini","Blyth, Phil","Chapman, Jamie A","Dayal, Manisha R","Flack, Natasha A M S","Fogg, Quentin A","Green, Rodney A","Hulme, Anneliese K","Johnson, Ian P","Meyer, Amanda J","Morley, John W","Shortland, Peter J","Strkalj, Goran","Strkalj, Mirjana","Valter, Krisztina","Webb, Alexandra L","Woodley, Stephanie J","Lazarus, Michelle D","32306555"],"abstract":["Australian and New Zealand universities commenced a new academic year in February/March 2020 largely with 'business as usual'. The subsequent COVID-19 pandemic imposed unexpected disruptions to anatomical educational practice. Rapid change occurred due to government-imposed physical distancing regulations from March 2020 that increasingly restricted anatomy laboratory teaching practices. Anatomy educators in both these countries were mobilized to adjust their teaching approaches. This study on anatomy education disruption at pandemic onset within Australia and New Zealand adopts a social constructivist lens. The research question was \"What are the perceived disruptions and changes made to anatomy education in Australia and New Zealand during the initial period of the Covid-19 pandemic, as reflected on by anatomy educators?\". Thematic analysis to elucidate ''the what and why'' of anatomy education was applied to these reflections. Eighteen anatomy academics from ten institutions participated in this exercise. The analysis revealed loss of integrated 'hands-on' experiences, and impacts on workload, traditional roles, students, pedagogy and anatomists' personal educational philosophies. The key opportunities recognized for anatomy education included: enabling synchronous teaching across remote sites, expanding offerings into the remote learning space, and embracing new pedagogies. In managing anatomy education's transition in response to the pandemic, six critical elements were identified: community care, clear communications, clarified expectations, constructive alignment, community of practice, ability to compromise and adapt and continuity planning. There is no doubt that anatomy education has stepped into a yet unknown future in the island countries of Australia and New Zealand."],"journal":"Anat Sci Educ","authors":["Pather, Nalini","Blyth, Phil","Chapman, Jamie A","Dayal, Manisha R","Flack, Natasha A M S","Fogg, Quentin A","Green, Rodney A","Hulme, Anneliese K","Johnson, Ian P","Meyer, Amanda J","Morley, John W","Shortland, Peter J","Strkalj, Goran","Strkalj, Mirjana","Valter, Krisztina","Webb, Alexandra L","Woodley, Stephanie J","Lazarus, Michelle D"],"date":"2020-04-20T11:00:00Z","year":2020,"_id":"32306555","week":"202017|Apr 20 - Apr 26","doi":"10.1002/ase.1968","keywords":["australia","covid-19 pandemic","new zealand","active learning","gross anatomy education","medical education","online delivery","online practical anatomy","reflective practices","remote learning","student wellbeing","workload"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["Australian","New Zealand","Australia","New Zealand","Australia","New Zealand","Australia","New Zealand","Australia","New Zealand"],"countries":["Australia","New Zealand"],"countries_codes":["AUS|Australia","NZL|New Zealand"],"_version_":1664641855781863424,"score":276.0687},{"pmid":32312892,"title":"Adapting to a pandemic - conducting oncology trials during the SARS-CoV-2 pandemic.","text":["Adapting to a pandemic - conducting oncology trials during the SARS-CoV-2 pandemic.","The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic has necessitated changes in cancer care delivery as resources are reallocated. Clinical trials and other research activities are inevitably impacted. Start-up activities for new trials may be deferred and recruitment suspended. For patients already enrolled however, there are challenges in continuing treatment on trial. Regulatory bodies have issued guidance on managing clinical trials during the pandemic, including contingency measures for remote study visits, delivery of investigational product and site monitoring visits. New cancer clinical trial practices during the SARS-CoV-2 pandemic include new risk assessment strategies, decentralized and remote trial co-ordination, data collection and delegation of specific therapeutic activities. This experience could provide evidence of more feasible and cost-effective methods for future clinical trial conduct.","Clin Cancer Res","Tan, Aaron C","Ashley, David M","Khasraw, Mustafa","32312892"],"abstract":["The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic has necessitated changes in cancer care delivery as resources are reallocated. Clinical trials and other research activities are inevitably impacted. Start-up activities for new trials may be deferred and recruitment suspended. For patients already enrolled however, there are challenges in continuing treatment on trial. Regulatory bodies have issued guidance on managing clinical trials during the pandemic, including contingency measures for remote study visits, delivery of investigational product and site monitoring visits. New cancer clinical trial practices during the SARS-CoV-2 pandemic include new risk assessment strategies, decentralized and remote trial co-ordination, data collection and delegation of specific therapeutic activities. This experience could provide evidence of more feasible and cost-effective methods for future clinical trial conduct."],"journal":"Clin Cancer Res","authors":["Tan, Aaron C","Ashley, David M","Khasraw, Mustafa"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32312892","week":"202017|Apr 20 - Apr 26","doi":"10.1158/1078-0432.CCR-20-1364","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664714520168235010,"score":270.9745},{"pmid":32275784,"title":"Telemedicine in Liver Disease and Beyond: Can the COVID-19 Crisis Lead to Action?","text":["Telemedicine in Liver Disease and Beyond: Can the COVID-19 Crisis Lead to Action?","Evidence strongly supports that access to specialty gastroenterology or hepatology care in cirrhosis is associated with higher adherence to guideline-recommended care and improves clinical outcomes. Presently, only about one half of acute care hospitalizations for cirrhosis-related complications result in inpatient specialty care and the current hepatology workforce cannot meet the demand of patients with liver disease nationwide, particularly in less densely populated areas and in community-based practices not affiliated with academic centers. Telemedicine, defined as the delivery of health care services at a distance using electronic means for diagnosis and treatment, holds tremendous promise to increase access to broadly specialty care. The technology is cheap and easy to use, however, is presently limited in scale by interstate licensing restrictions and reimbursement barriers. The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) has, in the short-term, accelerated the growth of telemedicine delivery as a public health and social distancing measure. Herein, we examine whether this public health crisis can accelerate the national conversation about broader adoption of telemedicine for routine medical care in non-crisis situations using a case series from our telehepatology program as a pragmatic example.","Hepatology","Serper, Marina","Cubell, Allen W","Deleener, Mary Elisabeth","Casher, Tara K","Rosenberg, Dale J","Whitebloom, Dale","Rosin, Roy M","32275784"],"abstract":["Evidence strongly supports that access to specialty gastroenterology or hepatology care in cirrhosis is associated with higher adherence to guideline-recommended care and improves clinical outcomes. Presently, only about one half of acute care hospitalizations for cirrhosis-related complications result in inpatient specialty care and the current hepatology workforce cannot meet the demand of patients with liver disease nationwide, particularly in less densely populated areas and in community-based practices not affiliated with academic centers. Telemedicine, defined as the delivery of health care services at a distance using electronic means for diagnosis and treatment, holds tremendous promise to increase access to broadly specialty care. The technology is cheap and easy to use, however, is presently limited in scale by interstate licensing restrictions and reimbursement barriers. The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) has, in the short-term, accelerated the growth of telemedicine delivery as a public health and social distancing measure. Herein, we examine whether this public health crisis can accelerate the national conversation about broader adoption of telemedicine for routine medical care in non-crisis situations using a case series from our telehepatology program as a pragmatic example."],"journal":"Hepatology","authors":["Serper, Marina","Cubell, Allen W","Deleener, Mary Elisabeth","Casher, Tara K","Rosenberg, Dale J","Whitebloom, Dale","Rosin, Roy M"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32275784","week":"202015|Apr 06 - Apr 12","doi":"10.1002/hep.31276","keywords":["connected health","hepatology","mhealth","telehealth","telehepatology"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664637190172311553,"score":244.17865}]}